We are live on ! Find out more
EVGN icon

Evogene
EVGN

33 hedge funds and large institutions have $45M invested in Evogene in 2020 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

375% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 4

100% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 4

83% more funds holding

Funds holding: 18 → 33 (+15)

34% more capital invested

Capital invested by funds: $33.6M → $45M (+$11.3M)

0% more ownership

Funds ownership: 2.68% → 2.69% (+0%)

Holders
33
Holders Change
+15
Holders Change %
+83.33%
% of All Funds
0.58%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
8
Reduced
4
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$911K
2
PP
PDT Partners
New York
+$289K
3
Jane Street
Jane Street
New York
+$258K
4
Squarepoint
Squarepoint
New York
+$236K
5
JF
Jump Financial
Illinois
+$225K

Top Sellers

Rank Fund Capital Flow
1
SM
Senvest Management
New York
-$504K
2
UBS Group
UBS Group
Switzerland
-$360K
3
PF
Phoenix Financial
Israel
-$188K
4
HIIFS
Harel Insurance Investments & Financial Services
Israel
-$139K
5
EVC
Eidelman Virant Capital
Missouri
-$136K
Name Holding Trade Value Shares
Change 		Change in
Stake
AIM
1
ARK Investment Management
Florida
$21.6M -$85.8K -2,435 -0.5%
WRF
2
Waddell & Reed Financial
Kansas
$13M – – –
SCM
3
Silverarc Capital Management
Massachusetts
$2.82M +$2.12M +60,000 New
SM
4
Senvest Management
New York
$2.23M -$504K -14,296 -23%
Morgan Stanley
5
Morgan Stanley
New York
$1.22M +$911K +25,835 +516,700%
Jane Street
6
Jane Street
New York
$825K +$258K +7,329 +72%
PP
7
PDT Partners
New York
$385K +$289K +8,199 New
Squarepoint
8
Squarepoint
New York
$365K +$236K +6,695 +620%
Royal Bank of Canada
9
Royal Bank of Canada
Ontario, Canada
$312K +$135K +3,840 +137%
JF
10
Jump Financial
Illinois
$300K +$225K +6,380 New
JP Morgan Chase
11
JP Morgan Chase
New York
$269K +$202K +5,716 New
VF
12
Virtu Financial
New York
$249K +$187K +5,303 New
LPL Financial
13
LPL Financial
California
$186K +$140K +3,959 New
Wells Fargo
14
Wells Fargo
California
$163K +$35.3K +1,000 +40%
MOS
15
MGO One Seven
Ohio
$144K +$108K +3,060 New
UBS Group
16
UBS Group
Switzerland
$129K -$360K -10,222 -79%
Susquehanna International Group
17
Susquehanna International Group
Pennsylvania
$124K +$39K +1,107 +72%
Commonwealth Equity Services
18
Commonwealth Equity Services
Massachusetts
$96K +$72.7K +2,063 New
Geode Capital Management
19
Geode Capital Management
Massachusetts
$89K +$66.9K +1,897 New
CAG
20
Csenge Advisory Group
Florida
$78K +$58.2K +1,650 New
EVC
21
Eidelman Virant Capital
Missouri
$71K -$136K -3,850 -72%
Dimensional Fund Advisors
22
Dimensional Fund Advisors
Texas
$63K +$47.6K +1,349 New
Janney Montgomery Scott
23
Janney Montgomery Scott
Pennsylvania
$61K +$45.4K +1,288 New
SPC
24
Sigma Planning Corp
Michigan
$56K +$42.3K +1,201 New
SW
25
SteelPeak Wealth
California
$50K +$37.4K +1,062 New
1
2

EVGN Hedge Fund Activity: Q4 2020 in Review

33 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Evogene (EVGN) for Q4 2020, worth a combined $45M — up 34% from $33.6M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new EVGN positions and 4 closed out — a net gain of 15 holders — while 8 added to existing stakes and 4 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $911K. The largest seller was Senvest Management, cutting an estimated $504K.

  • 33 institutional investors held Evogene (EVGN) as of Q4 2020, up from 18 in Q3 2020.
  • Funds reported $45M of Evogene stock for Q4 2020, up 34% quarter-over-quarter.
  • 19 funds opened new Evogene positions in Q4 2020 and 4 closed out, a net change of +15 holders.
  • The largest Evogene buyer in Q4 2020 was Morgan Stanley, an estimated $911K added.
  • The largest Evogene seller in Q4 2020 was Senvest Management, an estimated $504K sold.

Based on aggregated 13F filings for Q4 2020.